Game Your Health

“I prescribe this app to my patients.” Dr. Douglas Maurer, Program Director, Faculty Development Fellowship, Madigan Army Medical Center. Our independently clinically validated mental health video-game Sinasprite is the first to win a U.S. Surgeon General Award for our work with the military and the only one recommended by payers and providers today. Clinicians rely on our data to remotely monitor patients, identify high-risk patients, and receive reimbursement. We have worked with individuals diagnosed with anxiety, depression, substance abuse, bipolar, and severe mental illness. Per the economic analysis conducted by the University of Washington's Primary Care Innovation Lab, the estimated range of net revenue for clinics with 1000 patients on their panel is $19,526.78 to $23,556.78 per year to manage depression via Sinasprite and $2,073.69 to $2,501.67 per year for anxiety. Our self-help tools have the optional involvement of the clinician. As our product only requires a smartphone, Sinasprite can be immediately be played by many patients and their results be easily assessed by the clinical staff. This ease and immediate access to our tool plays a critical role in improving staffing efficiency.

“This is great data! I agree it is very encouraging ;) I will share this with the rest of our management team.” Catherine Stacey, Chief Clinical Officer, Assurance Health & Wellness. Our independently clinically validated mental health video-game Sinasprite is the first to win a U.S. Surgeon General Award for our work with the military and the only one recommended by payers and providers today. We have worked with individuals diagnosed with anxiety, depression, substance abuse, bipolar, and severe mental illness. For health systems, we can remotely monitor patients, identify high-risk individuals, provide reimbursement, and care documentation capabilities which easily integrate into current their workflow and help them meet requirements of outcomes-based contracts. With those health systems in competitive markets, our patient experiences provides differentiation and patient loyalty. Per the economic analysis conducted by the University of Washington's Primary Care Innovation Lab, the estimated range of net revenue for clinics with 1000 patients on their panel is $19,526.78 to $23,556.78 per year to manage depression via Sinasprite and $2,073.69 to $2,501.67 per year for anxiety. Our self-help tools have the optional involvement of the clinician. As our product only requires a smartphone, Sinasprite can be immediately be played by many patients and their results be easily assessed by the clinical staff. This ease and immediate access to our tool plays a critical role in improving staffing efficiency.

We’ve established mutually supportive global relationships where we inspire and accelerate the success of our colleagues and partners. With our pharma partners, such as Bayer, we are an adjunct digital therapeutic used to improve adherence and compliance. For our health plan partners, we help manage risk by scaling access to a mental health tool that improves clinical outcomes at lower costs by longitudinally engaging patients in self-care. We help them deploy new care models and strengthen their existing relationships with their provider groups. With those health plans in competitive markets, our patient experiences also provide differentiation and member loyalty. By interacting with us, our partner organizations have also gained new insights that made them think differently about commercializing innovations and the populations they serve.